No Data
Earnings Call Summary | Clover Health(CLOV.US) Q1 2025 Earnings Conference
Clover Health Targets 30% Medicare Advantage Growth and Raises 2025 EBITDA Guidance
Clover Health Reports Q1 EPS 0c, Consensus (7c)
Clover Health Narrows FY25 Adjusted EBITDA View to $50M-$70M From $45M-$70M
Earnings Flash (CLOV) Clover Health Investments Reports Q1 Revenue $462M, Vs. FactSet Est of $466.9M
Express News | Clover Health Investments: Outlook FY25 Insurance Revenue Between $1.800 Billion and $1.875 Billion